418 G. ROUSER, K. KELLY, B. JELINEK, D. HELLER 
200 
201 


, | + 
. ’ sats. 7 
ij . 
; 
Pigs. 195-204. From o.5 mi of plasma from patient R. Tho. (chronic lymphatic leukemia) after 
dimethylmyleran. Samples obtained 16h and 1, 2, 4, 6, 8, 12, 14, 16, and 23 days after drug. 
For abbreviations see p. 369. 
and ethanolamine-O-phosphate. Subsequent leukocyte samples indicate the high 
degree of reproducibility of the methods and demonstrate the extent to which 
variations are observed when a patient is examined over a period of several weeks. 
References p. 447/448 
